Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Verastem Inc (NASDAQ:VSTM)

1.07
Delayed Data
As of Dec 05
 -0.05 / -4.46%
Today’s Change
1.05
Today|||52-Week Range
2.09
-42.47%
Year-to-Date
No recent news for Verastem Inc.

Today’s Trading

Previous close1.12
Today’s open1.14
Day’s range1.07 - 1.17
Volume212,486
Average volume (3 months)200,944
Market cap$41.4M
Dividend yield--
Data as of 3:59pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)+22.22%
Earnings growth (this year)+43.23%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.40

Competitors

 Today’s
change
Today’s
% change
DNAIProNAi Therapeutics ...+0.11+8.03%
APVOAptevo Therapeutics ...+0.03+1.58%
MTFBMotif Bio PLC+0.21+3.97%
CYTRCytRx Corp-0.02-3.16%
Data as of 3:59pm ET, 12/05/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$0.00
Annual profit (last year)-$57.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert M. Forrester
Chief Operating Officer
Dan Paterson
Corporate headquarters
Needham, Massachusetts

Forecasts


Search for Jobs